Diebold Nixdorf (DBD) Research & Development (2009 - 2026)

Diebold Nixdorf's Research & Development history runs 18 years deep, the most recent figure standing at $22.1 million for Q1 2026.

• Quarterly Research & Development fell 2.64% year-over-year to $22.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.2 million (down 6.41% YoY) and the FY2025 annual result came in at $86.7 million, down 7.37% from the prior year.
• Research & Development was $22.1 million for Q1 2026 at Diebold Nixdorf, up from $21.4 million in the prior quarter.
• Across five years, Research & Development topped out at $33.1 million in Q2 2022 and bottomed at $12.0 million in Q3 2023.
• A 5-year average of $24.2 million and a median of $23.6 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development plunged 55.06% — and 2024, when it jumped 95.0%.
• Diebold Nixdorf's Research & Development stood at $28.6 million in 2022, then sank by 58.04% to $12.0 million in 2023, then jumped by 99.17% to $23.9 million in 2024, then dropped by 10.46% to $21.4 million in 2025, then rose by 3.27% to $22.1 million in 2026.
• Business Quant data shows DBD's Research & Development at $22.1 million in Q1 2026, $21.4 million in Q4 2025, and $20.3 million in Q3 2025.